BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 35259221)

  • 1. Arrhythmogenic Right Ventricular Cardiomyopathy: Overview and Case Study.
    Tennyson CD; Yapejian R
    AACN Adv Crit Care; 2022 Mar; 33(1):14-22. PubMed ID: 35259221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Orgeron GM; Crosson JE
    Cardiol Young; 2017 Jan; 27(S1):S57-S61. PubMed ID: 28084951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implantable Cardioverter-Defibrillator Therapy in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: Predictors of Appropriate Therapy, Outcomes, and Complications.
    Orgeron GM; James CA; Te Riele A; Tichnell C; Murray B; Bhonsale A; Kamel IR; Zimmerman SL; Judge DP; Crosson J; Tandri H; Calkins H
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28588093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in the Diagnosis and Management of Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy.
    Orgeron GM; Calkins H
    Curr Cardiol Rep; 2016 Jun; 18(6):53. PubMed ID: 27108363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sudden death related cardiomyopathies - Arrhythmogenic right ventricular cardiomyopathy, arrhythmogenic cardiomyopathy, and exercise-induced cardiomyopathy.
    Goff ZD; Calkins H
    Prog Cardiovasc Dis; 2019; 62(3):217-226. PubMed ID: 31004608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Arrhythmogenic right ventricular cardiomyopathy].
    Benn M; Hansen PS; Lund B; Schiønning JD; Baandrup U; Pedersen AK
    Ugeskr Laeger; 1998 Mar; 160(10):1454-9. PubMed ID: 9520612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anaesthetic implications of arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Alexoudis AK; Spyridonidou AG; Vogiatzaki TD; Iatrou CA
    Anaesthesia; 2009 Jan; 64(1):73-8. PubMed ID: 19087010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. QRS fragmentation and epsilon waves in Fontaine leads in arrhythmogenic right ventricular cardiomyopathy: re: "The use of fontaine leads in the diagnosis of arrhythmogenic right ventricular dysplasia" and "Arrhythmogenic right ventricular cardiomyopathy: contribution of different electrocardiographic techniques".
    Peters S
    Int J Cardiol; 2014 Oct; 176(3):1015-6. PubMed ID: 25115251
    [No Abstract]   [Full Text] [Related]  

  • 9. Diagnosis and management of arrhythmogenic right ventricular cardiomyopathy.
    Alblaihed L; Kositz C; Brady WJ; Al-Salamah T; Mattu A
    Am J Emerg Med; 2023 Mar; 65():146-153. PubMed ID: 36638611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnosis and therapy of arrhythmogenic right ventricular cardiomyopathy].
    Zorzi A; Rigato I; Migliore F; Perazzolo Marra M; Basso C; Thiene G; Bauce B; Corrado D
    G Ital Cardiol (Rome); 2014 Nov; 15(11):616-25. PubMed ID: 25424140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arrhythmogenic right ventricular dysplasia.
    Calkins H
    Curr Probl Cardiol; 2013 Mar; 38(3):103-23. PubMed ID: 23453020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding arrhythmogenic right ventricular cardiomyopathy.
    Welkie R
    JAAPA; 2023 May; 36(5):1-6. PubMed ID: 37097786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Arrhythmogenic right ventricular cardiomyopathy as a cause of sudden death in young people--literature review].
    Mazić S; Lazović B; Delić M
    Med Pregl; 2012; 65(9-10):396-404. PubMed ID: 23214333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The research venture in arrhythmogenic right ventricular cardiomyopathy: a paradigm of translational medicine.
    Thiene G
    Eur Heart J; 2015 Apr; 36(14):837-46. PubMed ID: 25636746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up of arrhythmogenic right ventricular cardiomyopathy patients with an implantable cardioverter-defibrillator for prevention of sudden cardiac death.
    Yin K; Ding L; Li Y; Hua W
    Clin Cardiol; 2017 Apr; 40(4):216-221. PubMed ID: 28139837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implantable cardioverter defibrillators in arrhythmogenic right ventricular dysplasia/cardiomyopathy: patient outcomes, incidence of appropriate and inappropriate interventions, and complications.
    Schinkel AF
    Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):562-8. PubMed ID: 23673907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arrhythmogenic right ventricular dysplasia/cardiomyopathy: review for the clinician.
    Ananthasubramaniam K; Khaja F
    Prog Cardiovasc Dis; 1998; 41(3):237-46. PubMed ID: 9872609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventing Sudden Death in Arrhythmogenic Cardiomyopathy: Careful Family and Genetic Evaluation Key to Appropriate Diagnosis and Management.
    Ortiz-Genga M; García-Hernández S; Monserrat-Iglesias L; McKenna WJ
    Can J Cardiol; 2021 Jun; 37(6):819-821. PubMed ID: 33359000
    [No Abstract]   [Full Text] [Related]  

  • 19. Implantable cardioverter-defibrillator shocks during long-term follow-up in arrhythmogenic right ventricular cardiomyopathy.
    Muller SA; Te Riele ASJM
    Heart; 2023 Jul; 109(15):1126-1127. PubMed ID: 36977546
    [No Abstract]   [Full Text] [Related]  

  • 20. Arrhythmogenic Cardiomyopathy.
    Corrado D; Basso C; Judge DP
    Circ Res; 2017 Sep; 121(7):784-802. PubMed ID: 28912183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.